Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Atossa Therapeutics, Inc. Common Stock

ATOS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ATOS by members of U.S. Congress

ATOS Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ATOS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ATOS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ATOS holdings by institutional investors

Quarterly net insider trading by ATOS's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $40,000 Jan 20, 2016 Issue: Medical/Disease Research/Clinical Labs
  • $40,000 Oct 20, 2015 Issue: Medical/Disease Research/Clinical Labs
  • $10,000 Sep 03, 2015 Issue: Medical/Disease Research/Clinical Labs

Former government officials who have lobbied for ATOS

2 former government officials from 1 congressional office at 1 lobbying firm have lobbied for ATOS, most recently May 13, 2020.

  • Patty Murray
    Rick Desimone Senate New Chief of Staff, Sen. Patty Murray Formerly with Patty Murray · DESIMONE CONSULTING, LLC · May 13, 2020
  • Patty Murray
    Brian Kristjansson Senate New State Director, Deputy State Director, Legislative Asst: Sen. Patty Murray Formerly with Patty Murray · DESIMONE CONSULTING, LLC · May 13, 2020

ATOS Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

ATOS Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ATOS Income Statement
ATOS Balance Sheet
ATOS Cash Flow
U.S. Patents

New ATOS patent grants

  • Patent Title: Heparin and n-acetylcysteine for the treatment of lung injury Mar. 17, 2026
  • Patent Title: Methods for making and using endoxifen Nov. 25, 2025
  • Patent Title: Methods for making and using endoxifen Apr. 22, 2025
  • Patent Title: Methods for making and using endoxifen Apr. 15, 2025
  • Patent Title: Sustained release compositions of endoxifen Jan. 21, 2025
  • Patent Title: Methods for making and using endoxifen Aug. 27, 2024
  • Patent Title: Methods for making and using endoxifen Jun. 20, 2023
  • Patent Title: Methods for making and using endoxifen Feb. 07, 2023
  • Patent Title: Methods for making and using endoxifen Mar. 01, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to ATOS from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ATOS News

Recent insights relating to ATOS

CNBC Recommendations

Recent picks made for ATOS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ATOS

ATOS Analyst Ratings

ATOS Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ATOS Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ATOS stock a Buy, Sell, or Hold?

  • What is the price target for $ATOS stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ATOS Top Shareholders
Shareholder
Shares Held
ATOS Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ATOS stock?

  • Who owns the most shares of $ATOS stock?

  • What funds own $ATOS stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ATOS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ATOS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ATOS

Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.

  • Address Seattle, WA
  • Market Cap 22.6 million
  • Employees 14
  • Industrial Classification Pharmaceutical Preparations

Atossa Therapeutics, Inc. Common Stock (ATOS) Historical Stock Prices

Atossa Therapeutics, Inc. Common Stock (ATOS) closed at $2.26 on September 22, 2026. Over the past year its adjusted close ranged from $1.75 to $17.70. Daily prices go back to January 2, 2014, 3,199 trading days in all.

  • 1 month-11.02%
  • 3 months+18.95%
  • Year to date-74.46%
  • 1 year-81.87%
  • 3 years-81.85%
  • 5 years-95.71%
  • Max-99.96%
See every congressional and insider trade on the ATOS price chart

Quiver Premium charts ATOS's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 2.25 2.43 2.25 2.26 2.26 129,526
Sep 21, 2026 2.25 2.39 2.25 2.25 2.25 67,169
Sep 18, 2026 2.37 2.38 2.22 2.22 2.22 39,755
Sep 17, 2026 2.42 2.43 2.37 2.40 2.40 33,288
Sep 16, 2026 2.39 2.48 2.39 2.42 2.42 45,776
Sep 15, 2026 2.48 2.49 2.37 2.37 2.37 43,779
Sep 14, 2026 2.53 2.56 2.45 2.48 2.48 35,039
Sep 11, 2026 2.36 2.54 2.36 2.51 2.51 60,410
Sep 10, 2026 2.36 2.61 2.33 2.34 2.34 47,238
Sep 9, 2026 2.54 2.54 2.40 2.40 2.40 24,800
Sep 8, 2026 2.49 2.59 2.44 2.52 2.52 41,370
Sep 4, 2026 2.51 2.60 2.50 2.52 2.52 28,028
Sep 3, 2026 2.50 2.60 2.46 2.53 2.53 56,692
Sep 2, 2026 2.40 2.51 2.39 2.46 2.46 44,771
Sep 1, 2026 2.48 2.50 2.32 2.42 2.42 92,004
Aug 31, 2026 2.57 2.59 2.50 2.50 2.50 53,194
Aug 28, 2026 2.62 2.62 2.50 2.58 2.58 49,003
Aug 27, 2026 2.64 2.69 2.58 2.64 2.64 23,115
Aug 26, 2026 2.66 2.70 2.61 2.65 2.65 26,301
Aug 25, 2026 2.62 2.69 2.58 2.68 2.68 49,690
Aug 24, 2026 2.56 2.65 2.45 2.64 2.64 57,149
Aug 21, 2026 2.59 2.62 2.51 2.54 2.54 25,656
Aug 20, 2026 2.62 2.62 2.44 2.59 2.59 70,954
Aug 19, 2026 2.57 2.76 2.55 2.64 2.64 62,197
Aug 18, 2026 2.77 2.78 2.56 2.59 2.59 58,563
Aug 17, 2026 2.62 2.97 2.55 2.79 2.79 192,438
Aug 14, 2026 2.54 2.69 2.43 2.60 2.60 96,120
Aug 13, 2026 2.36 2.56 2.35 2.56 2.56 83,113
Aug 12, 2026 2.32 2.37 2.27 2.35 2.35 31,349
Aug 11, 2026 2.39 2.45 2.27 2.36 2.36 56,704
Aug 10, 2026 2.26 2.45 2.26 2.37 2.37 69,086
Aug 7, 2026 2.37 2.45 2.24 2.36 2.36 78,020
Aug 6, 2026 2.39 2.44 2.26 2.42 2.42 30,786
Aug 5, 2026 2.37 2.39 2.27 2.39 2.39 36,767
Aug 4, 2026 2.18 2.34 2.18 2.31 2.31 54,974
Aug 3, 2026 2.10 2.19 2.07 2.17 2.17 24,344
Jul 31, 2026 2.19 2.19 2.05 2.07 2.07 79,045
Jul 30, 2026 2.29 2.29 2.18 2.19 2.19 32,533
Jul 29, 2026 2.37 2.39 2.28 2.31 2.31 40,884
Jul 28, 2026 2.36 2.49 2.33 2.42 2.42 45,915
Jul 27, 2026 2.30 2.45 2.30 2.36 2.36 36,741
Jul 24, 2026 2.41 2.46 2.25 2.29 2.29 40,789
Jul 23, 2026 2.44 2.55 2.41 2.41 2.41 37,171
Jul 22, 2026 2.43 2.49 2.37 2.43 2.43 26,603
Jul 21, 2026 2.46 2.60 2.39 2.40 2.40 106,083
Jul 20, 2026 2.48 2.58 2.40 2.49 2.49 117,295
Jul 17, 2026 2.39 2.50 2.27 2.49 2.49 47,873
Jul 16, 2026 2.42 2.46 2.34 2.39 2.39 68,960
Jul 15, 2026 2.29 2.44 2.23 2.44 2.44 97,154
Jul 14, 2026 2.35 2.36 2.23 2.26 2.26 157,797
Jul 13, 2026 2.37 2.42 2.21 2.40 2.40 177,603
Jul 10, 2026 2.37 2.39 2.22 2.37 2.37 65,745
Jul 9, 2026 2.42 2.42 2.27 2.36 2.36 144,165
Jul 8, 2026 2.51 2.54 2.38 2.45 2.45 127,999
Jul 7, 2026 2.37 2.60 2.19 2.49 2.49 426,355
Jul 6, 2026 2.14 2.41 2.14 2.28 2.28 228,476
Jul 2, 2026 2.03 2.19 2.03 2.12 2.12 116,527
Jul 1, 2026 1.95 2.06 1.92 2.04 2.04 144,223
Jun 30, 2026 1.98 2.01 1.93 1.93 1.93 73,951
Jun 29, 2026 1.90 2.04 1.89 1.98 1.98 181,707
Jun 26, 2026 1.76 1.91 1.73 1.88 1.88 377,885
Jun 25, 2026 1.77 1.78 1.70 1.77 1.77 143,643
Jun 24, 2026 1.89 1.89 1.75 1.75 1.75 304,043
Jun 23, 2026 1.82 1.96 1.78 1.90 1.90 535,003
Jun 22, 2026 2.03 2.03 1.81 1.83 1.83 469,933
Jun 18, 2026 2.01 2.02 1.95 2.01 2.01 193,503
Jun 17, 2026 2.21 2.21 1.95 1.99 1.99 696,590
Jun 16, 2026 2.36 2.38 2.16 2.22 2.22 310,191
Jun 15, 2026 2.51 2.51 2.31 2.35 2.35 477,652
Jun 12, 2026 2.57 2.70 2.45 2.46 2.46 644,745
Jun 11, 2026 2.81 2.81 2.52 2.58 2.58 1,419,877
Jun 10, 2026 4.39 4.59 4.36 4.40 4.40 29,976
Jun 9, 2026 4.55 4.59 4.36 4.41 4.41 53,900
Jun 8, 2026 4.56 4.56 4.35 4.55 4.55 36,026
Jun 5, 2026 4.78 4.80 4.40 4.47 4.47 80,972
Jun 4, 2026 4.67 4.87 4.65 4.85 4.85 46,839
Jun 3, 2026 4.80 4.80 4.68 4.70 4.70 45,089
Jun 2, 2026 5.06 5.14 4.80 4.85 4.85 77,731
Jun 1, 2026 5.14 5.20 4.93 5.11 5.11 58,520
May 29, 2026 5.21 5.30 5.00 5.23 5.23 42,911
May 28, 2026 5.19 5.25 4.98 5.19 5.19 51,710
May 27, 2026 4.95 5.18 4.86 5.12 5.12 40,167
May 26, 2026 4.95 5.05 4.86 4.95 4.95 30,310
May 22, 2026 4.93 5.10 4.84 4.96 4.96 28,196
May 21, 2026 4.79 5.06 4.66 4.97 4.97 55,013
May 20, 2026 4.71 4.96 4.66 4.84 4.84 38,794
May 19, 2026 4.80 4.92 4.66 4.75 4.75 50,575
May 18, 2026 4.85 4.95 4.70 4.78 4.78 43,054
May 15, 2026 5.11 5.11 4.85 4.85 4.85 46,175
May 14, 2026 5.16 5.16 4.95 5.15 5.15 29,915
May 13, 2026 5.23 5.31 5.15 5.16 5.16 31,995
May 12, 2026 5.43 5.43 5.08 5.16 5.16 60,136
May 11, 2026 5.58 5.71 5.45 5.50 5.50 37,720
May 8, 2026 5.42 5.65 5.42 5.60 5.60 31,401
May 7, 2026 5.81 5.83 5.61 5.67 5.67 47,864
May 6, 2026 5.53 5.89 5.49 5.80 5.80 60,166
May 5, 2026 5.86 6.18 5.24 5.58 5.58 199,073
May 4, 2026 5.33 5.97 5.33 5.86 5.86 98,641
May 1, 2026 5.43 5.43 5.16 5.33 5.33 35,695
Apr 30, 2026 5.28 5.46 5.19 5.37 5.37 24,715
Apr 29, 2026 5.47 5.51 5.21 5.28 5.28 28,962
Apr 28, 2026 5.49 5.74 5.32 5.49 5.49 29,616
Apr 27, 2026 5.68 5.78 5.32 5.45 5.45 36,791
Apr 24, 2026 5.73 5.80 5.54 5.70 5.70 42,677
Apr 23, 2026 5.93 5.93 5.61 5.73 5.73 39,354
Apr 22, 2026 5.87 6.02 5.75 5.95 5.95 40,243
Apr 21, 2026 6.20 6.20 5.76 5.77 5.77 91,412
Apr 20, 2026 5.83 6.28 5.80 6.17 6.17 127,941
Apr 17, 2026 5.81 5.94 5.67 5.83 5.83 54,755
Apr 16, 2026 5.64 5.78 5.52 5.77 5.77 34,062
Apr 15, 2026 5.37 5.76 5.35 5.74 5.74 100,072
Apr 14, 2026 5.30 5.44 5.23 5.35 5.35 35,516
Apr 13, 2026 4.92 5.36 4.92 5.31 5.31 71,445
Apr 10, 2026 4.99 4.99 4.81 4.94 4.94 30,144
Apr 9, 2026 4.84 5.05 4.73 4.98 4.98 42,925
Apr 8, 2026 5.08 5.13 4.73 4.82 4.82 76,981
Apr 7, 2026 5.15 5.15 4.70 4.88 4.88 81,510
Apr 6, 2026 5.41 5.41 5.10 5.15 5.15 54,707
Apr 2, 2026 5.01 5.56 5.00 5.37 5.37 71,797
Apr 1, 2026 5.27 5.36 5.03 5.11 5.11 63,323
Mar 31, 2026 4.77 5.26 4.77 5.26 5.26 42,716
Mar 30, 2026 4.79 4.87 4.59 4.71 4.71 39,160
Mar 27, 2026 4.60 4.92 4.60 4.72 4.72 64,924
Mar 26, 2026 5.19 5.47 4.64 4.71 4.71 124,096
Mar 25, 2026 5.57 6.09 5.40 5.42 5.42 130,343
Mar 24, 2026 5.61 5.69 5.39 5.51 5.51 41,253
Mar 23, 2026 5.37 5.71 5.35 5.61 5.61 65,601
Mar 20, 2026 5.17 5.98 5.12 5.33 5.33 159,493
Mar 19, 2026 5.11 5.35 4.96 5.13 5.13 65,957
Mar 18, 2026 5.50 5.53 5.10 5.11 5.11 47,225
Mar 17, 2026 4.98 5.57 4.98 5.49 5.49 64,526
Mar 16, 2026 5.06 5.18 4.90 4.97 4.97 38,959
Mar 13, 2026 5.08 5.22 4.95 5.01 5.01 105,749
Mar 12, 2026 4.73 5.38 4.71 5.05 5.05 146,890
Mar 11, 2026 4.73 4.85 4.61 4.78 4.78 42,775
Mar 10, 2026 4.58 4.87 4.56 4.78 4.78 125,425
Mar 9, 2026 4.53 4.60 4.36 4.57 4.57 129,981
Mar 6, 2026 4.56 4.67 4.44 4.53 4.53 46,266
Mar 5, 2026 4.92 5.01 4.52 4.68 4.68 70,850
Mar 4, 2026 4.79 5.12 4.71 4.92 4.92 136,510
Mar 3, 2026 4.54 4.91 4.31 4.72 4.72 104,103
Mar 2, 2026 4.35 4.55 4.23 4.50 4.50 88,389
Feb 27, 2026 4.43 4.59 4.35 4.43 4.43 69,292
Feb 26, 2026 4.36 4.59 4.30 4.47 4.47 90,814
Feb 25, 2026 4.23 4.44 4.15 4.27 4.27 79,022
Feb 24, 2026 4.01 4.27 4.00 4.21 4.21 96,340
Feb 23, 2026 4.11 4.15 3.83 3.96 3.96 105,477
Feb 20, 2026 4.38 4.48 4.15 4.21 4.21 43,948
Feb 19, 2026 4.35 4.55 4.20 4.42 4.42 78,783
Feb 18, 2026 4.06 4.59 4.06 4.34 4.34 85,710
Feb 17, 2026 4.14 4.20 3.97 4.15 4.15 92,805
Feb 13, 2026 3.92 4.44 3.91 4.20 4.20 94,578
Feb 12, 2026 4.05 4.15 3.76 3.94 3.94 247,216
Feb 11, 2026 4.76 4.77 4.03 4.05 4.05 348,441
Feb 10, 2026 4.91 5.05 4.80 4.82 4.82 190,583
Feb 9, 2026 5.32 5.33 4.78 4.99 4.99 325,429
Feb 6, 2026 5.33 5.54 5.21 5.34 5.34 156,117
Feb 5, 2026 5.03 5.47 5.01 5.33 5.33 186,706
Feb 4, 2026 5.41 5.51 4.92 5.29 5.29 283,041
Feb 3, 2026 5.60 5.85 4.91 5.53 5.53 640,110
Feb 2, 20261-for-15 reverse split 7.23 7.56 5.40 5.59 5.59 678,197
Jan 30, 2026 0.5961 0.5996 0.5321 0.5650 8.47 2,840,886
Jan 29, 2026 0.6171 0.6171 0.5700 0.6000 9.00 1,775,350
Jan 28, 2026 0.6730 0.6911 0.6100 0.6164 9.25 2,121,537
Jan 27, 2026 0.6998 0.7300 0.6610 0.6848 10.27 1,873,376
Jan 26, 2026 0.6333 0.7097 0.6025 0.6853 10.28 3,170,620
Jan 23, 2026 0.6600 0.6600 0.6300 0.6421 9.63 752,129
Jan 22, 2026 0.6200 0.6551 0.5920 0.6546 9.82 1,165,482
Jan 21, 2026 0.6000 0.6200 0.5850 0.6033 9.05 914,452
Jan 20, 2026 0.6605 0.6610 0.5801 0.6030 9.04 3,944,848
Jan 16, 2026 0.6109 0.6358 0.5900 0.6150 9.22 11,640,906
Jan 15, 2026 0.6100 0.6100 0.5708 0.5801 8.70 1,605,309
Jan 14, 2026 0.6280 0.6349 0.6000 0.6020 9.03 1,643,998
Jan 13, 2026 0.6600 0.6675 0.6349 0.6357 9.54 538,600
Jan 12, 2026 0.6425 0.6574 0.6163 0.6539 9.81 726,688
Jan 9, 2026 0.6600 0.6692 0.6301 0.6451 9.68 893,294
Jan 8, 2026 0.6700 0.6766 0.6350 0.6530 9.79 903,887
Jan 7, 2026 0.6700 0.6999 0.6566 0.6651 9.98 668,105
Jan 6, 2026 0.6100 0.6820 0.6081 0.6604 9.91 2,356,932
Jan 5, 2026 0.6498 0.6498 0.6000 0.6172 9.26 1,170,312
Jan 2, 2026 0.5926 0.6340 0.5926 0.6306 9.46 1,547,295
Dec 31, 2025 0.6000 0.6100 0.5510 0.5900 8.85 3,718,032
Dec 30, 2025 0.6510 0.6548 0.6151 0.6215 9.32 1,664,595
Dec 29, 2025 0.6440 0.6900 0.6440 0.6586 9.88 1,060,758
Dec 26, 2025 0.6800 0.6900 0.6479 0.6589 9.88 977,522
Dec 24, 2025 0.6800 0.6967 0.6650 0.6863 10.29 685,606
Dec 23, 2025 0.7035 0.7125 0.6661 0.6841 10.26 2,288,062
Dec 22, 2025 0.7320 0.7458 0.7116 0.7172 10.76 643,436
Dec 19, 2025 0.7100 0.7401 0.7015 0.7311 10.97 945,804
Dec 18, 2025 0.7088 0.7400 0.7000 0.7042 10.56 629,002
Dec 17, 2025 0.7399 0.7496 0.7120 0.7141 10.71 482,005
Dec 16, 2025 0.7000 0.7380 0.7000 0.7247 10.87 594,554
Dec 15, 2025 0.7400 0.7720 0.7000 0.7147 10.72 2,900,802
Dec 12, 2025 0.8817 0.9140 0.8202 0.8250 12.37 1,457,035
Dec 11, 2025 0.9600 0.9900 0.8944 0.9048 13.57 5,824,334
Dec 10, 2025 0.8199 0.8699 0.8031 0.8500 12.75 1,025,728
Dec 9, 2025 0.7816 0.8200 0.7816 0.8087 12.13 580,616
Dec 8, 2025 0.8200 0.8200 0.7700 0.7816 11.72 460,502
Dec 5, 2025 0.7800 0.8087 0.7671 0.7993 11.99 844,277
Dec 4, 2025 0.7428 0.7741 0.7340 0.7595 11.39 708,175
Dec 3, 2025 0.7090 0.7433 0.6950 0.7385 11.08 622,135
Dec 2, 2025 0.7293 0.7455 0.6848 0.7001 10.50 1,214,631
Dec 1, 2025 0.7914 0.7997 0.7400 0.7420 11.13 746,761
Nov 28, 2025 0.7915 0.7915 0.7710 0.7775 11.66 238,436
Nov 26, 2025 0.7750 0.8073 0.7718 0.7798 11.70 628,554
Nov 25, 2025 0.7571 0.7778 0.7516 0.7710 11.56 237,111
Nov 24, 2025 0.8000 0.8198 0.7484 0.7516 11.27 792,777
Nov 21, 2025 0.7533 0.7832 0.7437 0.7802 11.70 595,328
Nov 20, 2025 0.7637 0.7959 0.7520 0.7520 11.28 496,951
Nov 19, 2025 0.7900 0.7999 0.7583 0.7636 11.45 453,423
Nov 18, 2025 0.7748 0.8200 0.7721 0.7900 11.85 427,868
Nov 17, 2025 0.8100 0.8500 0.7701 0.7850 11.77 761,653
Nov 14, 2025 0.7900 0.8247 0.7790 0.8000 12.00 482,976
Nov 13, 2025 0.7974 0.8256 0.7700 0.8027 12.04 781,880
Nov 12, 2025 0.8277 0.8462 0.7912 0.8133 12.20 623,125
Nov 11, 2025 0.8400 0.8500 0.8100 0.8277 12.41 236,223
Nov 10, 2025 0.8300 0.8787 0.8300 0.8378 12.57 478,248
Nov 7, 2025 0.8000 0.8300 0.7800 0.8205 12.31 881,359
Nov 6, 2025 0.8300 0.8432 0.8113 0.8145 12.22 327,014
Nov 5, 2025 0.8400 0.8480 0.8250 0.8275 12.41 365,120
Nov 4, 2025 0.8556 0.8890 0.8401 0.8481 12.72 605,360
Nov 3, 2025 0.9000 0.9070 0.8534 0.8633 12.95 533,652
Oct 31, 2025 0.8730 0.9090 0.8700 0.8896 13.34 444,513
Oct 30, 2025 0.8650 0.8970 0.8600 0.8800 13.20 556,490
Oct 29, 2025 0.9276 0.9355 0.8596 0.8769 13.15 837,454
Oct 28, 2025 0.9430 0.9579 0.9307 0.9355 14.03 352,862
Oct 27, 2025 0.9332 0.9579 0.9200 0.9432 14.15 559,079
Oct 24, 2025 0.9200 0.9427 0.9103 0.9322 13.98 636,958
Oct 23, 2025 0.9252 0.9498 0.9003 0.9154 13.73 481,448
Oct 22, 2025 0.9700 0.9700 0.9010 0.9200 13.80 1,356,576
Oct 21, 2025 1.00 1.01 0.9616 0.9649 14.47 649,029
Oct 20, 2025 0.9981 1.01 0.9792 1.01 15.15 603,883
Oct 17, 2025 1.01 1.03 0.9540 0.9796 14.69 1,208,540
Oct 16, 2025 1.05 1.10 1.00 1.03 15.45 1,062,353
Oct 15, 2025 1.04 1.08 1.03 1.05 15.75 818,331
Oct 14, 2025 1.02 1.06 0.9604 1.03 15.45 1,532,021
Oct 13, 2025 1.12 1.15 1.04 1.05 15.75 1,551,180
Oct 10, 2025 1.17 1.20 1.05 1.08 16.20 2,434,272
Oct 9, 2025 1.13 1.29 1.12 1.18 17.70 4,372,876
Oct 8, 2025 1.01 1.16 1.01 1.11 16.65 4,132,034
Oct 7, 2025 1.00 1.02 0.9820 1.01 15.15 1,082,356
Oct 6, 2025 1.01 1.02 0.9702 1.00 15.00 1,296,501
Oct 3, 2025 0.9300 1.05 0.9221 1.01 15.15 3,027,753
Oct 2, 2025 0.9162 0.9260 0.8900 0.9200 13.80 816,528
Oct 1, 2025 0.8600 0.9300 0.8553 0.9162 13.74 1,167,728
Sep 30, 2025 0.8800 0.8900 0.8611 0.8670 13.00 373,571
Sep 29, 2025 0.8700 0.8990 0.8610 0.8727 13.09 918,905
Sep 26, 2025 0.8152 0.8592 0.8150 0.8585 12.88 465,210
Sep 25, 2025 0.8252 0.8410 0.8152 0.8167 12.25 331,442
Sep 24, 2025 0.8300 0.8473 0.8180 0.8255 12.38 400,817
Sep 23, 2025 0.8490 0.8668 0.8200 0.8229 12.34 957,652
Sep 22, 2025 0.8429 0.8490 0.8201 0.8309 12.46 468,613

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Atossa Therapeutics, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ATOS, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation